CLINICAL TRIALS PROFILE FOR FERRIC MALTOL
✉ Email this page to a colleague
All Clinical Trials for FERRIC MALTOL
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT01340872 ↗ | Safety and Efficacy Study of Oral Ferric Iron To Treat Iron Deficiency Anaemia in Quiescent Ulcerative Colitis (AEGIS-1) | Completed | Iron Therapeutics | Phase 3 | 2011-08-01 | The purpose of this study is to determine whether ST10-021, an oral ferric iron preparation, is safe and effective in the treatment of iron deficiency anaemia (IDA) in subjects with non-active ulcerative colitis (UC). |
| NCT01340872 ↗ | Safety and Efficacy Study of Oral Ferric Iron To Treat Iron Deficiency Anaemia in Quiescent Ulcerative Colitis (AEGIS-1) | Completed | Shield Therapeutics | Phase 3 | 2011-08-01 | The purpose of this study is to determine whether ST10-021, an oral ferric iron preparation, is safe and effective in the treatment of iron deficiency anaemia (IDA) in subjects with non-active ulcerative colitis (UC). |
| NCT01352221 ↗ | Safety and Efficacy Study of Oral Ferric Iron To Treat Iron Deficiency Anaemia in Quiescent Crohn's Disease (AEGIS-2) | Completed | Iron Therapeutics | Phase 3 | 2011-08-01 | The purpose of this study is to determine whether ST10-021, an oral ferric iron preparation, is safe and effective in the treatment of iron deficiency anaemia (IDA) in subjects with non-active Crohn's Disease (CD). |
| NCT01352221 ↗ | Safety and Efficacy Study of Oral Ferric Iron To Treat Iron Deficiency Anaemia in Quiescent Crohn's Disease (AEGIS-2) | Completed | Shield Therapeutics | Phase 3 | 2011-08-01 | The purpose of this study is to determine whether ST10-021, an oral ferric iron preparation, is safe and effective in the treatment of iron deficiency anaemia (IDA) in subjects with non-active Crohn's Disease (CD). |
| NCT02680756 ↗ | Safety and Efficacy Study of Oral Ferric Maltol Compared to Intravenous Iron To Treat Iron Deficiency Anaemia in IBD | Completed | Iron Therapeutics | Phase 3 | 2016-01-01 | The purpose of this study is to compare the efficacy of ferric maltol and intravenous iron (IVI) Ferric Carboxy Maltose in the treatment of iron deficiency anaemia (IDA) and subsequent maintenance of haemoglobin in subjects with Inflammatory Bowel Disease (IBD). |
| NCT02680756 ↗ | Safety and Efficacy Study of Oral Ferric Maltol Compared to Intravenous Iron To Treat Iron Deficiency Anaemia in IBD | Completed | Shield Therapeutics | Phase 3 | 2016-01-01 | The purpose of this study is to compare the efficacy of ferric maltol and intravenous iron (IVI) Ferric Carboxy Maltose in the treatment of iron deficiency anaemia (IDA) and subsequent maintenance of haemoglobin in subjects with Inflammatory Bowel Disease (IBD). |
| NCT02968368 ↗ | Study With Oral Ferric Maltol for the Treatment of Iron Deficiency Anemia in Subjects With Chronic Kidney Disease | Completed | Iron Therapeutics | Phase 3 | 2016-12-01 | To evaluate the efficacy of oral ferric maltol compared with placebo in the treatment of IDA in subjects with CKD |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for FERRIC MALTOL
Condition Name
Clinical Trial Locations for FERRIC MALTOL
Trials by Country
Clinical Trial Progress for FERRIC MALTOL
Clinical Trial Phase
Clinical Trial Sponsors for FERRIC MALTOL
Sponsor Name
